The Cytogenomics Shared Resource provides services for characterizing the chromosomal status of malignant and nonmalignant human and animal cells. The wide array of assays offered are aimed at identifying numerical and structural genomic aberrations that have a potential role in the etiology of tumor development. The wide diversity of technologies offered ensures that investigators have the means of confirming novel findings by multiple independent methods. The approaches used are continuously evolving to include state-of-the-art techniques and now include whole-genome microarray analysis and multiple ligation-dependent probe amplification (MLPA) in addition to fluorescence in situ hybridization (FISH), G-banding, and spectral karyotyping (SKY). Conventional karyotyping is used to provide critical quality control for experiments using embryonic stem cells, induced pluripotent cells, and other genetically manipulated cells. The Shared Resource also partners with the University of Minnesota Genomics Center to provide an expanded range of molecular genomic services, including gene expression analysis, gene knockdown, epigenomics, sequencing, and mutation detection assays. To help investigators stay abreast ofthe advances in the field, the Cytogenomics Shared Resource provides consultation on experimental design, selection of the most appropriate techniques, and interpretation of data. Since the inception of this Resource in 2003, Betsy Hirsch, PhD, has been the Director and LeAnn Oseth has served as the Coordinator. Both have decades of experience in cancer cytogenetics

National Institute of Health (NIH)
National Cancer Institute (NCI)
Center Core Grants (P30)
Project #
Application #
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Minnesota Twin Cities
United States
Zip Code
Abbott, Kenneth L; Nyre, Erik T; Abrahante, Juan et al. (2015) The Candidate Cancer Gene Database: a database of cancer driver genes from forward genetic screens in mice. Nucleic Acids Res 43:D844-8
Yee, Douglas (2015) A tale of two receptors: insulin and insulin-like growth factor signaling in cancer. Clin Cancer Res 21:667-9
Daniel, A R; Gaviglio, A L; Knutson, T P et al. (2015) Progesterone receptor-B enhances estrogen responsiveness of breast cancer cells via scaffolding PELP1- and estrogen receptor-containing transcription complexes. Oncogene 34:506-15
Upadhyaya, Pramod; Hecht, Stephen S (2015) Quantitative analysis of 3'-hydroxynorcotinine in human urine. Nicotine Tob Res 17:524-9
Patel, Yesha M; Stram, Daniel O; Wilkens, Lynne R et al. (2015) The contribution of common genetic variation to nicotine and cotinine glucuronidation in multiple ethnic/racial populations. Cancer Epidemiol Biomarkers Prev 24:119-27
Takahashi, Yutaka; Hui, Susanta K (2014) Fast, simple, and informative patient-specific dose verification method for intensity modulated total marrow irradiation with helical tomotherapy. Radiat Oncol 9:34
Cooley, Sarah; Weisdorf, Daniel J; Guethlein, Lisbeth A et al. (2014) Donor killer cell Ig-like receptor B haplotypes, recipient HLA-C1, and HLA-C mismatch enhance the clinical benefit of unrelated transplantation for acute myelogenous leukemia. J Immunol 192:4592-600
Chen, Liddy M; Ibrahim, Joseph G; Chu, Haitao (2014) Flexible stopping boundaries when changing primary endpoints after unblinded interim analyses. J Biopharm Stat 24:817-33
Landman, Sean R; Hwang, Tae Hyun; Silverstein, Kevin A T et al. (2014) SHEAR: sample heterogeneity estimation and assembly by reference. BMC Genomics 15:84
Gates, Leah A; Phillips, Martin B; Matter, Brock A et al. (2014) Comparative metabolism of furan in rodent and human cryopreserved hepatocytes. Drug Metab Dispos 42:1132-6

Showing the most recent 10 out of 319 publications